Phase II study of the anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody, tremelimumab, in patients with refractory metastatic colorectal cancer - Chung, K Y; Gore, I; Fong, L (J Clin Oncol, 2010)
, et al.